|
| 36649671 | Retrospective dataset and survey analyses identify gaps in data collection for craniopharyngioma and priorities of patients and families affected by the disease. | Neoplasia | 2023 |
| 32470710 | Adjuvant therapy with pegylated interferon-alfa2b vs observation in stage II B/C patients with ulcerated primary: Results of the European Organisation for Research and Treatment of Cancer 18081 randomised trial. | European Journal of Cancer | 2020 |
| 31633264 | Ambulatory emergency oncology: A key tenet of future emergency oncology care. | International Journal of Clinical Practice | 2020 |
| 31430371 | Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial. | Ann Oncol | 2019 |
| 32608386 | Ambulatory management in low risk neutropenic sepsis - A plea for integrated acute cancer care. | Acute Medicine | 2019 |
| 30428063 | Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial. | Annals of Oncology | 2019 |
| 28541108 | Using QR codes to enable quick access to information in acute cancer care. | British Journal of Nursing | 2017 |
| 27711083 | RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt. | British Journal of Cancer | 2016 |
| 27296487 | Validation of a Prognostic Staging for Metastatic Uveal Melanoma: A Collaborative Study of the European Ophthalmic Oncology Group. | Am J Ophthalmol | 2016 |
| 26921289 | Responding to Acute Care Needs of Patients With Cancer: Recent Trends Across Continents. | Oncologist | 2016 |
| 26913066 | An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients. | Ecancermedicalscience | 2016 |
| 27170310 | Patterns of acute oncology admissions: an exploratory analysis of over 7000 patient episodes. | Postgraduate Medical Journal | 2016 |
| 26278648 | Uveal Melanoma UK National Guidelines. | European Journal of Cancer | 2015 |
| 25542058 | Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative. | Eur J Cancer | 2015 |
| 25946135 | An Inducible TGF-β2-TGFβR Pathway Modulates the Sensitivity of HNSCC Cells to Tyrosine Kinase Inhibitors Targeting Dominant Receptor Tyrosine Kinases. | PLoS One | 2015 |
| 26134145 | Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation. | Health Technology Assessment | 2015 |
| 26407392 | Radiotherapy in the acute medical setting. | Clinical Medicine | 2015 |
| 25070647 | Multifocal calcifying fibrous tumor at six sites in one patient: a case report. | World Journal of Surgical Oncology | 2014 |
| 25301919 | Neutropenic sepsis: a potentially life-threatening complication of chemotherapy. | Clinical Medicine | 2014 |
| 24357463 | The Liverpool uveal melanoma liver metastases pathway: outcome following liver resection. | Journal of Surgical Oncology | 2014 |
| 24344211 | Phase II pilot study of intravenous high-dose interferon with or without maintenance treatment in melanoma at high risk of recurrence. | Journal of Clinical Oncology | 2014 |
| 24745696 | Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study. | Lancet Oncol | 2014 |
| 24510314 | Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial. | Annals of Oncology | 2014 |
| 23159448 | MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients. | British Journal of Ophthalmology | 2013 |
| 24114739 | Vemurafenib for the treatment of locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma: a NICE single technology appraisal. | PharmacoEconomics | 2013 |
| 24298102 | The impact of a new acute oncology service in acute hospitals: experience from the Clatterbridge Cancer Centre and Merseyside and Cheshire Cancer Network. | Clinical Medicine | 2013 |
| 23078958 | First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial. | Lancet Oncology, The | 2012 |
| 22741402 | Innovation: When the big 'C' stands for creativity. | Health service journal, The | 2012 |
| 22366043 | Increased numbers but functional defects of CD56+CD3+ cells in lung cancer. | International Immunology | 2012 |
| 21744082 | Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial. | Journal of Cancer Research and Clinical Oncology | 2011 |
| 21342183 | Increased killer immunoglobulin-like receptor expression and functional defects in natural killer cells in lung cancer. | Immunology | 2011 |
| 21029286 | Reconciling the principle of patient autonomy with the practice of informed consent: decision-making about prognostication in uveal melanoma. | Health Expectations | 2011 |
| 21684151 | Randomised phase II study of amrubicin as single agent or in combination with cisplatin versus cisplatin etoposide as first-line treatment in patients with extensive stage small cell lung cancer - EORTC 08062. | European Journal of Cancer | 2011 |
| 21673064 | Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck squamous cell carcinoma cells. | Clin Cancer Res | 2011 |
| 20600442 | Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors. | Hum Immunol | 2010 |
| 21152424 | Rapidly acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC cell lines through de-repression of FGFR2 and FGFR3 expression. | PLoS ONE | 2010 |
| 18344957 | Psychological aspects of cytogenetic testing of uveal melanoma: preliminary findings and directions for future research. | Eye | 2009 |
| 19501013 | The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancer. | Drug Resistance Updates | 2009 |
| 19536884 | Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma. | Cancer | 2009 |
| 19118055 | SCG3 transcript in peripheral blood is a prognostic biomarker for REST-deficient small cell lung cancer. | Clinical Cancer Research | 2009 |
| 18724618 | Chemotherapy induced febrile neutropenia: management and prevention. | Clinical Medicine | 2008 |
| 17899215 | Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice. | Supportive Care in Cancer | 2008 |
| 18082416 | Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. | Critical Reviews in Oncology/Hematology | 2008 |
| 18318916 | Extensive necrosis of visceral melanoma metastases after immunotherapy. | World Journal of Surgical Oncology | 2008 |
| 17545790 | Outpatient therapy for febrile neutropenia. | Current Opinion in Oncology | 2007 |
| 16718271 | A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma. | Melanoma Research | 2006 |
| 16648506 | Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06. | J Clin Oncol | 2006 |
| 16222310 | Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer. | British Journal of Cancer | 2005 |
| 16170175 | Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer. | Journal of Clinical Oncology | 2005 |
| 16333243 | Management of febrile neutropenia in the United Kingdom: time for a national trial? | British Journal of Cancer | 2005 |